» Articles » PMID: 33195342

Resuscitation After Hemorrhagic Shock in the Microcirculation: Targeting Optimal Oxygen Delivery in the Design of Artificial Blood Substitutes

Overview
Specialty General Medicine
Date 2020 Nov 16
PMID 33195342
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Microcirculatory preservation is essential for patient recovery from hemorrhagic shock. In hemorrhagic shock, microcirculatory flow and pressure are greatly reduced, creating an oxygen debt that may eventually become irreversible. During shock, tissues become hypoxic, cellular respiration turns to anaerobic metabolism, and the microcirculation rapidly begins to fail. This condition requires immediate fluid resuscitation to promote tissue reperfusion. The choice of fluid for resuscitation is whole blood; however, this may not be readily available and, on a larger scale, may be globally insufficient. Thus, extensive research on viable alternatives to blood has been undertaken in an effort to develop a clinically deployable blood substitute. This has not, as of yet, achieved fruition, in part due to an incomplete understanding of the complexities of the function of blood in the microcirculation. Hemodynamic resuscitation is acknowledged to be contingent on a number of factors other than volume expansion. The circulation of whole blood is carefully regulated to optimize oxygen delivery to the tissues shear stress modulation through blood viscosity, inherent oxygen-carrying capacity, cell-free layer variation, and myogenic response, among other variables. Although plasma expanders can address a number of these issues, hemoglobin-based oxygen carriers (HBOCs) introduce a method of replenishing the intrinsic oxygen-carrying capacity of blood. There continue to be a number of issues related to HBOCs, but recent advances in the next-generation HBOCs show promise in the preservation of microcirculatory function and limiting toxicities. The development of HBOCs is now focused on viscosity and the degree of microvascular shear stress achieved in order to optimize vasoactive and oxygen delivery responses by leveraging the restoration and maintenance of physiological responses to blood flow in the microcirculation. Blood substitutes with higher viscous properties tend to improve oxygen delivery compared to those with lower viscosities. This review details current concepts in blood substitutes, particularly as they relate to trauma/hemorrhagic shock, with a specific focus on their complex interactions in the microcirculation.

Citing Articles

Coadministration of PEGylated apohemoglobin and haptoglobin can limit vascular dysfunction in the microcirculation and prevent acute inflammation.

Munoz C, Lucas D, Muller C, Martinez J, OBoyle Q, Pires I J Appl Physiol (1985). 2024; 137(4):934-944.

PMID: 39143905 PMC: 11486475. DOI: 10.1152/japplphysiol.00315.2024.


Lactate and base excess (BE) as markers of hypoperfusion and mortality in traumatic hemorrhagic shock in patients undergoing Damage Control: a historical cohort.

Reese F, Hubert F, Cosentino M, Oliveira M, Rea Neto A, Bernardelli R Rev Col Bras Cir. 2024; 51:e20243699.

PMID: 38985036 PMC: 11449522. DOI: 10.1590/0100-6991e-20243699-en.


Nanomaterial-related hemoglobin-based oxygen carriers, with emphasis on liposome and nano-capsules, for biomedical applications: current status and future perspectives.

Zhu K, Wang L, Xiao Y, Zhang X, You G, Chen Y J Nanobiotechnology. 2024; 22(1):336.

PMID: 38880905 PMC: 11180412. DOI: 10.1186/s12951-024-02606-1.


Controlling heme redox properties in peptide amphiphile fibers with sequence and heme loading ratio.

Dutta C, Lopez V, Preston C, Rudra N, Chavez A, Rogers A Biophys J. 2024; 123(13):1781-1791.

PMID: 38783603 PMC: 11267424. DOI: 10.1016/j.bpj.2024.05.021.


Hydroxyethyl Starch-Bovine Hemoglobin Conjugate as an Effective Oxygen Carrier with the Ability to Expand Plasma.

Yan W, Sheng M, Yu W, Shen L, Qi J, Zhou H ACS Omega. 2023; 8(12):11447-11456.

PMID: 37008107 PMC: 10061510. DOI: 10.1021/acsomega.3c00275.


References
1.
Jahr J, Akha A, Holtby R . Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products. Curr Drug Discov Technol. 2011; 9(3):158-65. DOI: 10.2174/157016312802650742. View

2.
Nakayama S, Sibley L, Gunther R, Holcroft J, Kramer G . Small-volume resuscitation with hypertonic saline (2,400 mOsm/liter) during hemorrhagic shock. Circ Shock. 1984; 13(2):149-59. View

3.
Intaglietta M, Tompkins W . Microvascular measurements by video image shearing and splitting. Microvasc Res. 1973; 5(3):309-12. DOI: 10.1016/0026-2862(73)90042-3. View

4.
Liu Y, Li D, Chen J, Xie J, Bandyopadhyay S, Zhang D . Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10. Atherosclerosis. 2005; 188(1):19-27. DOI: 10.1016/j.atherosclerosis.2005.10.029. View

5.
Williams A, Lucas A, Muller C, Bolden-Rush C, Palmer A, Cabrales P . Balance between oxygen transport and blood rheology during resuscitation from hemorrhagic shock with polymerized bovine hemoglobin. J Appl Physiol (1985). 2020; 129(1):97-107. PMC: 7469229. DOI: 10.1152/japplphysiol.00016.2020. View